Capital Performance Advisors’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-8
Closed -$17 2030
2024
Q3
$17 Buy
+8
New +$17 ﹤0.01% 2863